The Society of Neuro-Oncology

What The Society of Neuro-Oncology does

The Society for Neuro-Oncology (SNO) is a 501(c)(3) non-profit professional organization incorporated in Texas on January 31, 1996, and headquartered at PO Box 273296, Houston, TX 77277-3296. SNO operates as the world's largest multidisciplinary organization dedicated to advancing research, education, and patient care for brain and spinal cord tumors, serving more than 3,000 members across over 60 countries that include neuro-oncologists, neurosurgeons, radiation oncologists, neuropathologists, neuroradiologists, basic and translational researchers, allied health professionals, and patient advocates. Its product surface spans a family of three peer-reviewed journals — Neuro-Oncology (the flagship, IF 16.4), Neuro-Oncology Practice, and the open-access Neuro-Oncology Advances (joint with EANO) — published in partnership with Oxford University Press; the Neuro-Oncology Academy online education and CME platform; the SNO Central member community platform built on Higher Logic infrastructure; the weekly SNO Digest newsletter; Neuro-Oncology: The Podcast; and the annual SNO Annual Meeting & Education Day (2,500+ attendees) alongside the co-branded SNO/ASCO CNS Metastases Conference, the Clinical Trials Design Workshop, and the Pediatric Neuro-Oncology Conference. The SNO Foundation ('Beat Brain Cancer') funds translational grants such as the Early Career Catalyst Grants, and the SNO Future Leaders Development Program cultivates early-career physician-scientists.

The organization runs on a diversified non-profit revenue model with no PE/VC ownership: annual membership dues across six tiered categories (Full $545, Trainee $95, Emeritus $125, Allied Health $145, International Outreach $175, and free Student), conference and workshop registration fees, journal subscriptions and 20%-discounted article processing charges (APCs) routed through Oxford University Press, and platinum-level sponsorships from pharmaceutical, biotech, and patient-advocacy funders (Chimerix, Novocure, Servier, Springworks TX, Telix Pharmaceuticals, ABTA, NBTS, The Sontag Foundation). The society's GTM is membership-driven: it acquires and retains members through annual conferences, educational programs, peer-reviewed publications, mentorship, and the integrated digital community. Operationally, SNO is supported by a small core staff of approximately 10 administrative and program professionals overseen by Executive Director J. Charles (Chas) Haynes, JD, with elected officer leadership (President Eva Galanis, President-Elect Shawn Hervey-Jumper, Secretary-Treasurer Adrienne Boire) and a representative Board of Directors structured by neuro-oncology subspecialty.

Name

The Society of Neuro-Oncology

Legal name

Society for Neuro-Oncology

Website

https://soc-neuro-onc.org

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

51–100 employees

Short description

The Society for Neuro-Oncology (SNO) is a Houston-based 501(c)(3) non-profit professional society founded in 1996, serving 3,000+ members across 60+ countries with peer-reviewed journals, annual conferences, CME education, and community platforms for the multidisciplinary brain and spinal cord tumor field.

Ownership category

akta.pro rank

Product category

Professional Medical Association

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Neuro-Oncology (HLAKAFAH)

Keywords

• Professional medical society
• Neuro-oncology research
• Continuing medical education
• Peer-reviewed journals
• Scientific conferences

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Dues: Annual membership fees from Full ($545), Trainee ($95), Emeritus ($125), Allied Health ($145), International Outreach ($175), and Student ($0) members. Membership year runs January-December with journal subscriptions included.
2. Conference and Meeting Registration: Revenue from registration fees for Annual Meeting, SNO/ASCO CNS Metastases Conference, Clinical Trials Workshop, Pediatric Conference, and other educational events
3. Journal Publications: Revenue from publication fees, article processing charges (APCs), and manuscript acceptance fees for Neuro-Oncology, Neuro-Oncology Practice, and Neuro-Oncology Advances journals. 20% discounted APC for SNO members.
4. Sponsorships and Exhibits: Platinum supporters and sponsors provide funding including ABTA, Chimerix, NBTS, Novocure, Servier, Springworks TX, Telix, and The Sontag Foundation

Pricing tiers

Distribution channels4 records

Marketing channels7 records

Core offering

The Society of Neuro-Oncology (SNO) operates a multidisciplinary professional society delivering membership services, peer-reviewed scientific journals (Neuro-Oncology, Neuro-Oncology Advances, Neuro-Oncology Practice), annual and specialized conferences, continuing medical education through the Neuro-Oncology Academy, mentorship and career development programs, and grant funding through its Beat Brain Cancer foundation for physicians, scientists, allied health professionals, and advocates in the brain and spinal cord tumor field.

Product overview

The Society for Neuro-Oncology operates as a membership-based professional organization offering a portfolio of educational, publishing, and community services rather than a traditional software product. The core offerings include three peer-reviewed journals (Neuro-Oncology as the flagship journal, Neuro-Oncology Advances as open access, and Neuro-Oncology Practice), the Neuro-Oncology Academy education platform, the SNO Central member community platform, the weekly SNO Digest newsletter, and Neuro-Oncology: The Podcast. The society organizes major conferences including the Annual Meeting & Education Day and SNO/ASCO CNS Metastases Conference, along with specialized workshops like the Clinical Trial Design and Protocol Development Workshop. Additional programs include the Future Leaders Development Program, Career Center, and the Beat Brain Cancer foundation.

Differentiator

Problem solved

Functional benefit

Brands

• Beat Brain Cancer: The Foundation of the Society for Neuro-Oncology, dedicated to supporting the fight against brain cancer by advancing research, driving discovery for neuro-oncology professionals, and providing essential resources and hope to patients and their families.
• Neuro-Oncology Academy
• SNO Central
• Neuro-Oncology: The Podcast

Products and services

• Neuro-Oncology Academy An online education platform offering live and on-demand continuing medical education content for multidisciplinary neuro-oncology professionals.
• Neuro-Oncology: The Podcast A podcast series providing educational content and discussions on neuro-oncology topics for professionals in the field.
• Neuro-Oncology (Journal) The flagship peer-reviewed monthly journal of SNO covering all areas of neuro-oncology, with a 2023 Impact Factor of 16.4, published through Oxford University Press.
• Neuro-Oncology Advances An open access interdisciplinary journal covering basic, applied, and clinical investigations in cancer and the central nervous system, jointly owned by SNO and the European Association of Neuro-Oncology.
• Neuro-Oncology Practice A bi-monthly peer-reviewed journal providing practical guidance for neuro-oncology professionals.
• SNO Central An online member community platform featuring discussions, library resources, blogs, and networking capabilities, powered by Higher Logic.
• SNO Digest A weekly email newsletter providing the latest news in neuro-oncology, including publications, clinical trials, upcoming meetings, and SNO announcements.
• SNO Annual Meeting & Education Day The largest multidisciplinary neuro-oncology meeting, bringing together over 2,500 professionals annually to advance research, education, and patient care for brain and spinal cord tumors.
• SNO/ASCO CNS Metastases Conference A specialized conference focused on CNS metastases research and treatment, co-organized with ASCO.
• Clinical Trial Design and Protocol Development Workshop An annual workshop providing foundational didactic background knowledge and mentored clinical trial design opportunities for neuro-oncology investigators, with CME credit eligibility.
• SNO Future Leaders Development Program A ten-month leadership development program cultivating careers and training young physician-scientists to become future leaders in neuro-oncology through mentorship and a formalized training curriculum.
• SNO Career Center A job board and career resources platform connecting neuro-oncology professionals with employment opportunities.
• Beat Brain Cancer Foundation The Foundation of SNO dedicated to advancing brain cancer research, funding early-career grants including the Early Career Catalyst Grants, and providing resources to patients and families.

Quantifiable outcome

• Neuro-Oncology journal ranked 15 out of 322 in Oncology and 4 out of 277 in Clinical Neurology (2023)
• +1 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eight partnerships are on record, tiered core and secondary.

• ASCO (American Society of Clinical Oncology)coreStrategic or Co-development Partner · 13 August 2026Joint conference partnership for the annual SNO/ASCO CNS Metastases Conference. The 2026 conference will be held August 13-15, 2026 in Boston, Massachusetts, focusing on CNS metastases research and treatment.
• European Association of Neuro-Oncology (EANO)coreStrategic or Co-development PartnerJoint ownership of Neuro-Oncology Advances journal (open access interdisciplinary journal). EANO co-sponsors awards and shares editorial leadership across the neuro-oncology publishing portfolio.
• Asian Society for Neuro-OncologycoreStrategic or Co-development PartnerPartner in editorial leadership of Neuro-Oncology Advances journal, sharing executive editorial representation alongside SNO and EANO.
• Japan Society for Neuro-OncologysecondaryStrategic or Co-development PartnerAffiliated society for Neuro-Oncology journal, contributing to the global reach and collaboration in neuro-oncology research publication.
• Beat Brain CancercoreStrategic or Co-development PartnerThe Foundation of the Society for Neuro-Oncology, dedicated to supporting the fight against brain cancer by advancing research, driving discovery for neuro-oncology professionals, and providing resources and hope to patients and families. Funds Early Career Catalyst Grants.
• World Federation of Neuro-Oncology Societies (WFNOS)coreStrategic or Co-development PartnerQuadrennial meeting held in conjunction with SNO Annual Meeting. The 2025 meeting was held in Honolulu, Hawaii alongside SNO's 30th Annual Meeting.
• Oxford University PresscoreStrategic or Co-development PartnerPublishing partner for SNO's family of journals including Neuro-Oncology, Neuro-Oncology Practice, and Neuro-Oncology Advances.
• Higher LogicsecondaryTechnology or IntegrationTechnology platform provider powering SNO Central online community platform for member discussions, networking, and resource sharing.

Scale indicators5 records

Recent moves9 records

Expansion highlights5 records

Broad incumbents

• American Academy of Neurology (AAN): AAN is the largest US neurology professional society, serving the broader neurology specialty of which neuro-oncology is a subspecialty. AAN's annual meeting and Neurology journal overlap with SNO's neurologist members and clinical content.
• American Society of Clinical Oncology (ASCO): ASCO is the largest professional oncology society globally and SNO's formal partner on the annual SNO/ASCO CNS Metastases Conference. ASCO serves the broader oncology community of which neuro-oncology is a subspecialty, overlapping with SNO's clinician base.
• Society for Neuroscience (SfN): SfN is the world's largest neuroscience professional organization with 30,000+ members. Its annual meeting and Journal of Neuroscience reach basic neuroscience researchers whose work intersects with brain tumor biology — overlapping with SNO's research constituency.
• American Association for Cancer Research (AACR): AACR is the largest cancer research organization, publishing multiple high-impact journals (Cancer Discovery, Clinical Cancer Research). AACR's research and publication footprint competes for the same neuro-oncology researchers who submit to SNO's journals.
• Congress of Neurological Surgeons (CNS): CNS is the leading neurosurgical society with a dedicated Section on Tumors (which co-awards the Abhijit Guha Award with SNO). Neurosurgery is a core discipline within SNO's multidisciplinary scope, making CNS a relevant adjacent society.
• American Society for Radiation Oncology (ASTRO): ASTRO is the premier radiation oncology society with its own annual meeting and the Red Journal (International Journal of Radiation Oncology, Biology, Physics). Radiation oncology is a core neuro-oncology discipline represented on SNO's board, making ASTRO an adjacent specialty peer.

Regional players

• Asian Society for Neuro-Oncology (ASNO): ASNO is a co-editorial partner on Neuro-Oncology Advances and serves the Asian neuro-oncology community. It overlaps directly with SNO's mission regionally, offering an alternative convening body for Asian-based SNO members.

Direct peers

• World Federation of Neuro-Oncology Societies (WFNOS): WFNOS is the global umbrella federation of national neuro-oncology societies, holding quadrennial meetings in conjunction with SNO's Annual Meeting. WFNOS complements SNO's mission of uniting neuro-oncology professionals across geographies.
• European Association of Neuro-Oncology (EANO): EANO is the direct European counterpart to SNO and a formal co-owner of the Neuro-Oncology Advances journal, jointly sponsoring awards and editorial leadership. The two societies serve overlapping physician/researcher constituencies in neuro-oncology and operate parallel annual meetings.

Emerging players

• Children's Oncology Group (COG): COG is the largest pediatric cancer research collaborative, including a dedicated brain tumor committee that runs clinical trials in pediatric neuro-oncology. COG's research mission overlaps with SNO's pediatric neuro-oncology community and grants portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

• Xx.com/neuroonc
• LinkedInlinkedin.com/company/society-for-neuro-oncology

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Society of Neuro-Oncology